Literature DB >> 17493689

The involvement of mitochondria in the pathogenesis of multiple sclerosis.

Bernadette Kalman1, Karen Laitinen, Samuel Komoly.   

Abstract

Multiple sclerosis is an immune-mediated disorder of the central nervous system. Major pathological characteristics include the loss of oligodendrocytes, demyelination and neuroaxonal depletion in association with inflammation. The complex pathophysiology of tissue loss is only partially understood. Here we discuss a variety of mitochondrion-driven mechanisms involved in immune regulation, oligodendrocyte depletion and neurodegeneration. The recognition of a mitochondrial link between inflammation and neurodegeneration underscores the importance of an early aggressive intervention for halting inflammation and preventing neurodegeneration, and identifies the mitochondrion as a potential target in neuroprotection.

Entities:  

Mesh:

Year:  2007        PMID: 17493689     DOI: 10.1016/j.jneuroim.2007.03.020

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  34 in total

1.  Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla.

Authors:  M Inglese; G Madelin; N Oesingmann; J S Babb; W Wu; B Stoeckel; J Herbert; G Johnson
Journal:  Brain       Date:  2010-01-27       Impact factor: 13.501

2.  Mitochondrial DNA haplogroups and mutations in children with acquired central demyelination.

Authors:  S Venkateswaran; K Zheng; M Sacchetti; D Gagne; D L Arnold; A D Sadovnick; S W Scherer; B Banwell; A Bar-Or; D K Simon
Journal:  Neurology       Date:  2011-02-02       Impact factor: 9.910

3.  Variations in mitochondrial DNA copy numbers in MS brains.

Authors:  Andrei Blokhin; Tamara Vyshkina; Samuel Komoly; Bernadette Kalman
Journal:  J Mol Neurosci       Date:  2008-06-20       Impact factor: 3.444

Review 4.  SIRT1 and NAD+ precursors: Therapeutic targets in multiple sclerosis a review.

Authors:  Vamshi K C Nimmagadda; Tapas K Makar; Krish Chandrasekaran; Avinash Rao Sagi; Jayanta Ray; James W Russell; Christopher T Bever
Journal:  J Neuroimmunol       Date:  2016-07-17       Impact factor: 3.478

5.  Lack of mitochondrial DNA deletions in lesions of multiple sclerosis.

Authors:  Andrei Blokhin; Tamara Vyshkina; Samuel Komoly; Bernadette Kalman
Journal:  Neuromolecular Med       Date:  2008       Impact factor: 3.843

6.  Role of autophagy in the pathogenesis of multiple sclerosis.

Authors:  Peizhou Liang; Weidong Le
Journal:  Neurosci Bull       Date:  2015-08-08       Impact factor: 5.203

7.  Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression.

Authors:  William T Regenold; Pornima Phatak; Michael J Makley; Roger D Stone; Mitchel A Kling
Journal:  J Neurol Sci       Date:  2008-09-09       Impact factor: 3.181

8.  Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients(♦).

Authors:  Soheila Rezapour-Firouzi; Seyed Rafie Arefhosseini; Mehdi Farhoudi; Mehrangiz Ebrahimi-Mamaghani; Mohammad-Reza Rashidi; Mohammad-Ali Torbati; Behzad Baradaran
Journal:  Bioimpacts       Date:  2012-10-28

9.  Oxidative stress is differentially present in multiple sclerosis courses, early evident, and unrelated to treatment.

Authors:  Maira Gironi; Bruno Borgiani; Enrica Mariani; Cristina Cursano; Laura Mendozzi; Rossella Cavarretta; Marina Saresella; Mario Clerici; Giancarlo Comi; Marco Rovaris; Roberto Furlan
Journal:  J Immunol Res       Date:  2014-03-26       Impact factor: 4.818

Review 10.  Mitochondrial involvement in psychiatric disorders.

Authors:  Ling Shao; Maureen V Martin; Stanley J Watson; Alan Schatzberg; Huda Akil; Richard M Myers; Edward G Jones; William E Bunney; Marquis P Vawter
Journal:  Ann Med       Date:  2008       Impact factor: 4.709

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.